Goodrx Holdings, Inc. balance sheet
At the end of fiscal 2025, Goodrx Holdings, Inc. had total assets of $1.40bn, total liabilities of $788m and shareholders' equity of $616m. It held $262m in cash against $495m of debt: net debt of $233m.
Balance sheet
| Fiscal year | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 35 | 26 | 969 | 941 | 757 | 672 | 448 | 262 | 296 |
| Receivables | — | 48 | 69 | 118 | 117 | 144 | 146 | 236 | 182 |
| Total current assets | — | 87 | 1,086 | 1,089 | 920 | 873 | 659 | 643 | 1,599 |
| Goodwill | 220 | 236 | 261 | 330 | 412 | 411 | 411 | 430 | 430 |
| Total assets | — | 387 | 1,470 | 1,608 | 1,605 | 1,589 | 1,388 | 1,404 | 2,343 |
| Accounts payable | — | 8 | 10 | 18 | 18 | 36 | 14 | 19 | 9 |
| Deferred revenue (current) | — | 3 | 7 | 7 | 8 | 7 | 6 | 7 | 9 |
| Total current liabilities | — | 33 | 60 | 81 | 76 | 123 | 124 | 246 | 1,158 |
| Short-term debt | — | 7 | 7 | 7 | 7 | 9 | 5 | 5 | 5 |
| Long-term debt | — | 664 | 660 | 656 | 652 | 648 | 487 | 483 | 482 |
| Total debt | 0 | 671 | 681 | 674 | 667 | 656 | 500 | 495 | 487 |
| Total liabilities | — | 737 | 759 | 776 | 790 | 827 | 663 | 788 | 1,695 |
| Shareholders' equity | −1,162 | −1,088 | 711 | 832 | 815 | 762 | 725 | 616 | 648 |
| Non-controlling interests and other (assets − liabilities − equity) | — | 737 | — | — | — | — | — | — | — |
| Net debt (negative = net cash) | −35 | 645 | −288 | −267 | −90 | −16 | 52 | 233 | 190 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 131 | 146 | 160 | 189 | 204 | 236 | 233 | 182 |
| Total current assets | 627 | 659 | 540 | 551 | 566 | 643 | 1,266 | 1,599 |
| Goodwill | 411 | 411 | 422 | 422 | 422 | 430 | 430 | 430 |
| Total assets | 1,355 | 1,388 | 1,295 | 1,319 | 1,326 | 1,404 | 2,021 | 2,343 |
| Accounts payable | 12 | 14 | 15 | 25 | 29 | 19 | 15 | 9 |
| Deferred revenue (current) | 6 | 6 | 6 | 6 | 6 | 7 | 9 | 9 |
| Total current liabilities | 114 | 124 | 103 | 131 | 182 | 246 | 859 | 1,158 |
| Short-term debt | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Long-term debt | 488 | 487 | 486 | 485 | 484 | 483 | 482 | 482 |
| Total debt | 491 | 492 | 491 | 490 | 489 | 488 | 487 | 487 |
| Total liabilities | 658 | 663 | 641 | 676 | 725 | 788 | 1,399 | 1,695 |
| Shareholders' equity | 696 | 725 | 654 | 643 | 601 | 616 | 622 | 648 |
Compare with peers
- Doximity, Inc. balance sheet
- Phreesia, Inc. balance sheet
- Omnicell, Inc. balance sheet
- Waystar Holding Corp. balance sheet
- Genedx Holdings Corp. balance sheet
Head to head: DOCS vs GDRXGDRX vs PHRGDRX vs OMCLGDRX vs WAY
More: Health Care Technology stocks compared, Health Care sector, rankings of US companies